NasdaqCM - Nasdaq Real Time Price • USD
eFFECTOR Therapeutics, Inc. (EFTR)
As of 11:16 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 44,302 | 3 |
| Sales | 609,163 | 1 |
| Net Shares Purchased (Sold) | -564,861 | 4 |
| Total Insider Shares Held | 133.74k | -- |
| % Net Shares Purchased (Sold) | -80.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LLC Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.61 per share. | Indirect | 369,457 | Nov 27, 2023 |
| BYRNES MICHAEL Chief Financial Officer | Stock Award(Grant) at price 0.50 per share. | Direct | 2,250 | Nov 15, 2023 |
| WORLAND STEPHEN T Chief Executive Officer | Stock Award(Grant) at price 0.50 per share. | Direct | 2,973 | Nov 15, 2023 |
| WORLAND STEPHEN T Chief Executive Officer | Conversion of Exercise of derivative security at price 0.52 per share. | Direct | 17,575 | Aug 11, 2023 |
| BYRNES MICHAEL Chief Financial Officer | Stock Award(Grant) at price 0.68 per share. | Direct | 3,331 | May 15, 2023 |
| WORLAND STEPHEN T Chief Executive Officer | Stock Award(Grant) at price 0.68 per share. | Direct | 4,384 | May 15, 2023 |
| BYRNES MICHAEL Chief Financial Officer | Stock Award(Grant) at price 0.47 per share. | Direct | 2,179 | Nov 15, 2022 |
| WORLAND STEPHEN T Chief Executive Officer | Stock Award(Grant) at price 0.47 per share. | Direct | 2,832 | Nov 15, 2022 |
| EHRLICH CHRISTOPHER B Director | Purchase at price 0.57 per share. | Direct | 197 | Oct 4, 2022 |
| EHRLICH CHRISTOPHER B Director | Purchase at price 0.55 per share. | Direct | 10,377 | Sep 26, 2022 |
| PRESIDIO MANAGEMENT GROUP X L L C Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.79 - 0.80 per share. | Indirect | 91,203 | Aug 3, 2022 |
| U.S. VENTURE PARTNERS Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.89 per share. | Indirect | 29,005 | Jul 28, 2022 |
| PRESIDIO MANAGEMENT GROUP X L L C Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.89 - 0.93 per share. | Indirect | 43,580 | Jul 27, 2022 |
| PRESIDIO MANAGEMENT GROUP X L L C Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.91 - 1.00 per share. | Indirect | 19,514 | Jul 22, 2022 |
| PRESIDIO MANAGEMENT GROUP X L L C Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.00 - 1.11 per share. | Indirect | 76,278 | Jul 19, 2022 |
| GALLAGHER BRIAN M JR. Director | Purchase at price 1.59 per share. | Direct | 47,700 | Jun 23, 2022 |
| BYRNES MICHAEL Chief Financial Officer | Purchase at price 1.33 per share. | Direct | 33,262 | Jun 7, 2022 |
| WORLAND STEPHEN T Chief Executive Officer | Purchase at price 1.37 per share. | Direct | 27,400 | Jun 7, 2022 |
| PRESIDIO MANAGEMENT GROUP X L L C Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.69 - 1.75 per share. | Indirect | 59,496 | May 19, 2022 |
| PRESIDIO MANAGEMENT GROUP X L L C Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.75 - 2.00 per share. | Indirect | 85,501 | May 16, 2022 |
| BYRNES MICHAEL Chief Financial Officer | Stock Award(Grant) at price 1.53 per share. | Direct | 6,476 | May 13, 2022 |
| WORLAND STEPHEN T Chief Executive Officer | Stock Award(Grant) at price 1.53 per share. | Direct | 2,811 | May 13, 2022 |
| U.S. VENTURE PARTNERS Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.34 - 2.54 per share. | Indirect | 118,351 | May 11, 2022 |
| EHRLICH CHRISTOPHER B Director | Purchase at price 4.30 - 4.45 per share. | Direct | 13,200 | Feb 18, 2022 |
| EHRLICH CHRISTOPHER B Director | Purchase at price 4.75 - 4.92 per share. | Direct | 9,670 | Feb 9, 2022 |
| EHRLICH CHRISTOPHER B Director | Purchase at price 5.00 - 5.15 per share. | Direct | 30,750 | Feb 4, 2022 |
| EHRLICH CHRISTOPHER B Director | Purchase at price 5.30 per share. | Direct | 26,515 | Jan 27, 2022 |
| ROOT JONATHAN D Director and Beneficial Owner of more than 10% of a Class of Security | Sale at price 5.68 per share. | Indirect | 46,082 | Dec 2, 2021 |
| PRESIDIO MANAGEMENT GROUP X L L C Beneficial Owner of more than 10% of a Class of Security | Sale at price 5.68 per share. | Indirect | 46,082 | Dec 2, 2021 |
| U.S. VENTURE PARTNERS Beneficial Owner of more than 10% of a Class of Security | Sale at price 5.68 per share. | Indirect | 46,082 | Dec 2, 2021 |
| ROOT JONATHAN D Director and Beneficial Owner of more than 10% of a Class of Security | Sale at price 6.44 - 6.70 per share. | Indirect | 475,406 | Dec 1, 2021 |
| PRESIDIO MANAGEMENT GROUP X L L C Beneficial Owner of more than 10% of a Class of Security | Sale at price 6.44 - 6.70 per share. | Indirect | 475,406 | Dec 1, 2021 |
| U.S. VENTURE PARTNERS Beneficial Owner of more than 10% of a Class of Security | Sale at price 6.44 - 6.70 per share. | Indirect | 475,406 | Dec 1, 2021 |
| ROOT JONATHAN D Director and Beneficial Owner of more than 10% of a Class of Security | Sale at price 7.01 - 7.40 per share. | Indirect | 413,996 | Nov 26, 2021 |
| PRESIDIO MANAGEMENT GROUP X L L C Beneficial Owner of more than 10% of a Class of Security | Sale at price 7.01 - 7.40 per share. | Indirect | 413,996 | Nov 26, 2021 |
| U.S. VENTURE PARTNERS Beneficial Owner of more than 10% of a Class of Security | Sale at price 7.01 - 7.40 per share. | Indirect | 413,996 | Nov 26, 2021 |
| ROOT JONATHAN D Director and Beneficial Owner of more than 10% of a Class of Security | Sale at price 7.86 - 8.53 per share. | Indirect | 407,404 | Nov 22, 2021 |
| PRESIDIO MANAGEMENT GROUP X L L C Beneficial Owner of more than 10% of a Class of Security | Sale at price 7.86 - 8.53 per share. | Indirect | 407,404 | Nov 22, 2021 |
| U.S. VENTURE PARTNERS Beneficial Owner of more than 10% of a Class of Security | Sale at price 7.86 - 8.53 per share. | Indirect | 407,404 | Nov 22, 2021 |
| ROOT JONATHAN D Director and Beneficial Owner of more than 10% of a Class of Security | Sale at price 9.13 - 9.81 per share. | Indirect | 221,523 | Nov 17, 2021 |
| PRESIDIO MANAGEMENT GROUP X L L C Beneficial Owner of more than 10% of a Class of Security | Sale at price 9.13 - 9.81 per share. | Indirect | 221,523 | Nov 17, 2021 |
| U.S. VENTURE PARTNERS Beneficial Owner of more than 10% of a Class of Security | Sale at price 9.13 - 9.81 per share. | Indirect | 221,523 | Nov 17, 2021 |
| ROOT JONATHAN D Director and Beneficial Owner of more than 10% of a Class of Security | Sale at price 10.07 - 11.00 per share. | Indirect | 917,006 | Nov 12, 2021 |
| PRESIDIO MANAGEMENT GROUP X L L C Beneficial Owner of more than 10% of a Class of Security | Sale at price 10.07 - 11.00 per share. | Indirect | 917,006 | Nov 12, 2021 |
| U.S. VENTURE PARTNERS Beneficial Owner of more than 10% of a Class of Security | Sale at price 10.07 - 11.00 per share. | Indirect | 917,006 | Nov 12, 2021 |
| ROOT JONATHAN D Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 - 16.98 per share. | Indirect | 12,103,089 | Aug 25, 2021 |
| EHRLICH CHRISTOPHER B Director | -- | Indirect | -- | Aug 25, 2021 |
| SMITHER JOHN W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 25, 2021 |
| GALLAGHER BRIAN M JR. Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Aug 25, 2021 |
| BHATT ELIZABETH Director | -- | Indirect | -- | Aug 25, 2021 |
Related Tickers
PDSB PDS Biotechnology Corporation
3.2500
0.00%
XFOR X4 Pharmaceuticals, Inc.
1.2287
-4.75%
VINC Vincerx Pharma, Inc.
0.8900
-4.30%
DAWN Day One Biopharmaceuticals, Inc.
13.45
-11.45%
MREO Mereo BioPharma Group plc
2.7600
-0.72%
AMLX Amylyx Pharmaceuticals, Inc.
1.8100
-3.72%
ABEO Abeona Therapeutics Inc.
3.1500
-0.63%
CLRB Cellectar Biosciences, Inc.
3.0000
-1.96%
APVO Aptevo Therapeutics Inc.
0.6700
-1.85%
MRNS Marinus Pharmaceuticals, Inc.
1.3900
-3.46%